Ligand gets $10M credit line; Crowley ready to return to Amicus; Clues on Alzheimer's;

@FierceBiotech: Competition gets fierce for innovative science. Report | Follow @FierceBiotech 

@JohnCFierce: Chatted with Ian Tomlinson, worldwide business czar for GSK. Can't say I learned much new, though oncology, inflammation are a hot deal source. | Follow @JohnCFierce

> Square 1 Bank has extended a credit facility totaling $10 million to La Jolla, CA-based Ligand Pharmaceuticals. Ligand release

> With his temporary tour of duty in the Navy Reserve coming to an end Amicus Therapeutics said that John Crowley is returning as chairman and CEO. Amicus release

> SciFluor Life Sciences has appointed Arthur Hiller, recent CEO of venture-backed cardiovascular device start-up Heartscape Technologies, as its CEO. Release

Pharma News

@FiercePharma: Can we foot the bill for pricey prostate-cancer meds? Article | Follow @FiercePharma

>  Vertex jumps on early hep C scrip numbers. Article

> Patients, scientists square off on Avastin at FDA. Item

> J&J: Working together, not marketing together. Story

> Musty smell touches off yet another J&J recall. Report

> Icahn sues Forest for info on Solomon's woes. Piece

Drug Delivery News

> Australia's Mesoblast says the FDA has cleared its plans for a clinical trial on a stem cell therapy for lower back pain. Story

> Red-blooded delivery device gets by body's defenses. Report

> MEMS implant could target diabetic retinopathy. Article

> Nebraska nanoscientist returns to Mother Russia with $4.5M grant. Story

> Digna to use Flamel's drug-delivery technologies in three products. Article

> Pop goes the nanotube for targeted drug delivery. Item

> Defense Department interested in Impel's BBB-busting device. Report

Medical Device News

> Allegro enters agreement with schools for lung cancer testing platform. Story

> Live from BIO 2011: Polybatics looks to improve diagnostics through beads. Report

> InfraReDx raises $24.1M from equity offering. Article

> Medtronic's Infuse targeted in scientific journal. News

> Medtronic introduces mobile app for use with cardiac devices. Report

And Finally... Scientists at the University of South Florida say they have begun to puzzle out how coffee appears to protect people from Alzheimer's. Report

Suggested Articles

Reata’s bardoxolone improved kidney function in a phase 3 trial of patients with a rare form of chronic kidney disease.

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.